Works matching Investigational therapies
Results: 1521
Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats.
- Published in:
- Veterinary & Comparative Oncology, 2021, v. 19, n. 2, p. 311, doi. 10.1111/vco.12677
- By:
- Publication type:
- Article
Review article: clinical pharmacology of current and investigational hepatitis B virus therapies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 2, p. 231, doi. 10.1111/apt.15581
- By:
- Publication type:
- Article
Consent concerns in clinical trials of investigational therapies for COVID-19: Vulnerability versus voluntariness.
- Published in:
- Perspectives in Clinical Research, 2020, v. 11, n. 4, p. 174, doi. 10.4103/picr.PICR_271_20
- By:
- Publication type:
- Article
Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy.
- Published in:
- Cell Journal (Yakhteh), 2020, v. 21, n. 4, p. 433, doi. 10.22074/cellj.2020.6309
- By:
- Publication type:
- Article
Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, p. 1, doi. 10.1186/s13045-021-01113-2
- By:
- Publication type:
- Article
Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update.
- Published in:
- Journal of Experimental Pharmacology, 2021, v. 13, p. 329, doi. 10.2147/JEP.S265286
- By:
- Publication type:
- Article
Investigational Microbiome Therapy to Reduce CDI Recurrence.
- Published in:
- Indian Practitioner, 2020, v. 73, n. 9, p. 61
- Publication type:
- Article
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies.
- Published in:
- Medicinal Research Reviews, 2020, v. 40, n. 1, p. 245, doi. 10.1002/med.21601
- By:
- Publication type:
- Article
Hepatitis D infection: from initial discovery to current investigational therapies.
- Published in:
- Gastroenterology Report, 2019, v. 7, n. 4, p. 231, doi. 10.1093/gastro/goz023
- By:
- Publication type:
- Article
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.
- Published in:
- Expert Review of Clinical Immunology, 2020, v. 16, n. 12, p. 1185, doi. 10.1080/1744666X.2021.1847084
- By:
- Publication type:
- Article
Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8436, doi. 10.3390/ijms21228436
- By:
- Publication type:
- Article
Investigational Therapies and Patients' Autonomy.
- Published in:
- Canadian Journal of Bioethics / Revue canadienne de bioéthique, 2020, v. 3, n. 3, p. 115, doi. 10.7202/1073786ar
- By:
- Publication type:
- Article
Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies.
- Published in:
- Clinical Ophthalmology, 2024, v. 18, p. 2283, doi. 10.2147/OPTH.S465143
- By:
- Publication type:
- Article
Four cases of investigational therapy with interleukin-11 against acute myocardial infarction.
- Published in:
- Heart & Vessels, 2016, v. 31, n. 9, p. 1574, doi. 10.1007/s00380-015-0788-4
- By:
- Publication type:
- Article
THE LATEST "FEDERAL MOVEMENT" IN THE FOOD AND DRUG LAW ARENA: THE FEDERAL RIGHT-TO-TRY OR RATHER RIGHT-TO-KNOW AND THUS REQUEST INVESTIGATIONAL THERAPIES FOR INDIVIDUALS WITH A LIFE-THREATENING DISEASE OR CONDITION.
- Published in:
- Indiana Health Law Review, 2018, v. 16, n. 1, p. 101
- By:
- Publication type:
- Article
Hereditary angioedema: Investigational therapies and future research.
- Published in:
- Allergy & Asthma Proceedings, 2020, v. 41, p. S51, doi. 10.2500/aap.2020.41.200056
- By:
- Publication type:
- Article
Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1376551
- By:
- Publication type:
- Article
First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1376551
- By:
- Publication type:
- Article
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 8, p. 2307, doi. 10.1007/s10067-020-04970-3
- By:
- Publication type:
- Article
Patient and public involvement and engagement in the development of innovative patient-centric early phase dose-finding trial designs.
- Published in:
- Research Involvement & Engagement, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40900-024-00599-7
- By:
- Publication type:
- Article
Statistical considerations in clinical trial design with event‐free survival as the primary efficacy endpoint.
- Published in:
- Pharmaceutical Statistics, 2021, v. 20, n. 4, p. 721, doi. 10.1002/pst.2103
- By:
- Publication type:
- Article
The mandate for investigational cancer therapies.
- Published in:
- Physician Executive, 1995, v. 21, n. 9, p. 46
- By:
- Publication type:
- Article
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1017, doi. 10.1002/cncr.34609
- By:
- Publication type:
- Article
Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 591, doi. 10.1002/cpt.3000
- By:
- Publication type:
- Article
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01014-8
- By:
- Publication type:
- Article
Postoperative Cognitive Dysfunction after Coronary Artery Bypass Grafting.
- Published in:
- Brazilian Journal of Cardiovascular Surgery, 2019, v. 34, n. 1, p. 76, doi. 10.21470/1678-9741-2018-0165
- By:
- Publication type:
- Article
Clinical presentation and management of COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- journal article
FDA Unveils Pilot Program to Expand Access to Investigational Oncology Drugs.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 1
- By:
- Publication type:
- Article
Current experimental therapies for atypical and malignant meningiomas.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 153, n. 2, p. 203, doi. 10.1007/s11060-021-03759-x
- By:
- Publication type:
- Article
Workshop summary: Potential usefulness and feasibility of a US National Mesothelioma Registry.
- Published in:
- American Journal of Industrial Medicine, 2020, v. 63, n. 2, p. 105, doi. 10.1002/ajim.23062
- By:
- Publication type:
- Article
Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Biomedicines, 2021, v. 9, n. 7, p. 705, doi. 10.3390/biomedicines9070705
- By:
- Publication type:
- Article
Where Can Patients Obtain Information on the Preapproval Access Pathway to Investigational Treatment in Japan? A Survey of Patient Advocacy Organizations' Websites.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 8, p. 978, doi. 10.1002/cpdd.745
- By:
- Publication type:
- Article
Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist--a pragmatic tool to accelerate development of cell therapy products.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02147-6
- By:
- Publication type:
- Article
Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist—a pragmatic tool to accelerate development of cell therapy products.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02147-6
- By:
- Publication type:
- Article
Diagnosis and Management of Obsessive-Compulsive Disorder in the Primary Care Setting.
- Published in:
- American Family Physician, 2024, v. 110, n. 4, p. 385
- By:
- Publication type:
- Article
Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies.
- Published in:
- Dermatology Online Journal, 2019, v. 25, n. 10, p. 1, doi. 10.5070/d32510045810
- By:
- Publication type:
- Article
Precision Medicine and the Institutional Review Board: Ethics and the Genome.
- Published in:
- Ochsner Journal, 2020, v. 20, n. 1, p. 98, doi. 10.31486/toj.19.0098
- By:
- Publication type:
- Article
Low-Grade Glioma Clinical Trials in the United States: A Systematic Review.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 9, p. 1133, doi. 10.3390/life14091133
- By:
- Publication type:
- Article
Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies.
- Published in:
- Expert Review of Clinical Immunology, 2020, v. 16, n. 1, p. 63, doi. 10.1080/1744666X.2019.1705784
- By:
- Publication type:
- Article
Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease.
- Published in:
- Expert Review of Clinical Immunology, 2019, v. 15, n. 10, p. 1009, doi. 10.1080/1744666X.2020.1668269
- By:
- Publication type:
- Article
The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 96, n. 1, p. 115, doi. 10.1007/s11060-009-0058-3
- By:
- Publication type:
- Article
Investigational Cell Therapy Cuts Insulin Dependency in Late-Stage Type 2 Diabetes.
- Published in:
- Patient Care (Online), 2025, p. 5
- By:
- Publication type:
- Article
A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 6, p. 975, doi. 10.1002/pst.2049
- By:
- Publication type:
- Article
Investigational Maintenance Therapy Extends Survival in AML.
- Published in:
- ONS Voice, 2020, v. 35, n. 5, p. 19
- By:
- Publication type:
- Article
HBV and HDV: New Treatments on the Horizon.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4054, doi. 10.3390/jcm10184054
- By:
- Publication type:
- Article
Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11493-2
- By:
- Publication type:
- Article
Current status and research directions in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01143-2
- By:
- Publication type:
- Article
Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples.
- Published in:
- Frontiers in Endocrinology, 2019, p. 1, doi. 10.3389/fendo.2019.00612
- By:
- Publication type:
- Article
Knowledge base toward understanding actionable alterations and realizing precision oncology.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 2, p. 123, doi. 10.1007/s10147-018-1378-0
- By:
- Publication type:
- Article